@misc{kadali_janagama_peruru_racherla_tirumala_madathala_gajula_2021, title={Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms}, volume={225}, ISSN={["1097-6868"]}, DOI={10.1016/j.ajog.2021.06.007}, abstractNote={Adverse effects of COVID-19 messenger RNA vaccines among pregnant women: a cross-sectional study on healthcare workers with detailed self-reported symptoms a The participant with a report of seizure has a known history of seizure disorder and her anticonvulsant blood level was reported as borderline low; b The pregnancy-related adverse events were very rarely reported (gestational hypertension [1 in 38], threatened labor [1 in 38], miscarriage [1 in 38], and premature delivery [1 in 38]) from the Pfizer-BioNTech vaccine group and none were reported from the Moderna group.}, number={4}, journal={AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY}, author={Kadali, Renuka Ananth Kalyan and Janagama, Ravali and Peruru, Sharanya R. and Racherla, Shailaja and Tirumala, Radhika and Madathala, Rajasekhar R. and Gajula, Viswanath}, year={2021}, month={Oct}, pages={458–460} }
 @article{kadali_janagama_peruru_gajula_madathala_chennaiahgari_malayala_2021, title={Non-life-threatening adverse effects with COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms}, volume={93}, ISSN={["1096-9071"]}, DOI={10.1002/jmv.26996}, abstractNote={Abstract}, number={7}, journal={JOURNAL OF MEDICAL VIROLOGY}, author={Kadali, Renuka Ananth Kalyan and Janagama, Ravali and Peruru, Sharanya and Gajula, Viswanath and Madathala, Rajasekhar R. and Chennaiahgari, Nikhita and Malayala, Srikrishna V.}, year={2021}, month={Jul}, pages={4420–4429} }
 @article{kadali_janagama_peruru_malayala_2021, title={Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers}, volume={106}, ISSN={["1878-3511"]}, DOI={10.1016/j.ijid.2021.04.047}, abstractNote={IntroductionConcerns are prevailing about the safety and side effects of the BNT162b2 mRNA vaccine for coronavirus disease 2019 (COVID-19).MethodsA randomized, cross-sectional study was performed to investigate the side effects of the BNT162b2 vaccine using an independent online questionnaire gathering responses from healthcare workers (HCWs) with detailed review of organ systems.ResultsOf all HCWs, 87.98% (1245/1415) completed the survey. Of them, 64.5% (803/1245) received the BNT162b2 mRNA vaccine and reported at least one or more symptoms (classified based on organ systems and occurrence rate) post vaccination. Of these, 640/803 (79.7%) were able to continue activities of daily living (ADL), 103/803 (12.83%) had trouble temporarily to perform ADL, 99/803 (12.33%) took time off work temporarily, 20/803 (2.49%) required help from an outpatient provider, 5/803 (0.62%) required help from an emergency department and 2/803 (0.25%) required hospitalization. Despite this, 97.61% intended to have the second dose and 92.9% had already received it.ConclusionsCommonly reported symptoms (occurrence in descending order) were soreness, fatigue, myalgia, headache, chills, fever, joint pain, nausea, muscle spasm, sweating, dizziness, flushing, feelings of relief, brain fogging, anorexia, localized swelling, decreased sleep quality, itching, tingling, diarrhoea, nasal stuffiness and palpitations. Despite this, remarkable acceptance for the second dose of the BNT162b2 vaccine was found among HCWs.}, journal={INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES}, author={Kadali, Renuka A. K. and Janagama, Ravali and Peruru, Sharanya and Malayala, Srikrishna V}, year={2021}, month={May}, pages={376–381} }